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Summary
Objective: Artificial intelligence (AI) provides people and 
professionals working in the field of participatory health informatics 
an opportunity to derive robust insights from a variety of online 
sources. The objective of this paper is to identify current state of the 
art and application areas of AI in the context of participatory health. 
Methods: A search was conducted across seven databases 
(PubMed, Embase, CINAHL, PsychInfo, ACM Digital Library, 
IEEExplore, and SCOPUS), covering articles published since 
2013. Additionally, clinical trials involving AI in participatory 
health contexts registered at clinicaltrials.gov were collected and 
analyzed.
Results: Twenty-two articles and 12 trials were selected for 
review. The most common application of AI in participatory 
1   Introduction 
Over the last decade, the role of people (or 
patients) in managing their own health or 
healthcare has changed dramatically [1, 2]. A 
significant paradigm shift has been observed, 
whereby individuals have moved from being 
passengers in the health journey to more 
active, engaged, and empowered partners 
in the shared decision-making process with 
health was the secondary analysis of social media data: 
self-reported data including patient experiences with healthcare 
facilities, reports of adverse drug reactions, safety and efficacy 
concerns about over-the-counter medications, and other 
perspectives on medications. Other application areas included 
determining which online forum threads required moderator 
assistance, identifying users who were likely to drop out from 
a forum, extracting terms used in an online forum to learn its 
vocabulary, highlighting contextual information that is missing 
from online questions and answers, and paraphrasing technical 
medical terms for consumers.
Conclusions: While AI for supporting participatory health is 
still in its infancy, there are a number of important research 
priorities that should be considered for the advancement of the 
field. Further research evaluating the impact of AI in participatory 
health informatics on the psychosocial wellbeing of individuals 
would help in facilitating the wider acceptance of AI into the 
healthcare ecosystem.
Keywords
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their health professionals [2-4]. New ways of 
creating, developing, and consuming health 
care goods and services have arisen known 
as participatory health or the participatory 
health paradigm. Participatory health infor-
matics involves individuals and representa-
tives of those individuals who would be the 
main beneficiaries of this technology [5, 6]. 
Participatory health focuses on patient-cen-
tered initiatives to empower individuals in 
making more informed health decisions 
where the individual/patient is at the center 
of any related healthcare initiative [7]. The 
term was first coined in 2008 [7]. For exam-
ple, Eytan provides a definition that suggests 
participatory health: “Enabled by informa-
tion, software, and community that we col-
lect or create, we the patients can be effective 
partners in our own health care, and we the 
people can participate in reshaping the health 
Published online: 25.04.2019
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system itself.” [8]. Furst further describes 
participatory health as “care characterized by 
the ability to rapidly share, classify, and sum-
marize individual health information with 
the goals of improving health care systems, 
experiences, and outcomes via integration 
of patients and stakeholders.” [9]. A number 
of informatics-related tools can be used in 
participatory health activities such as: social 
media, mobile phone health apps, personal 
health records, health social networks, con-
sumer genomics, and crowdsourced health 
studies [4, 8, 9]. Each enables the generation, 
production, or collection of various types of 
data, reflecting several facets of one’s health 
which includes psychological, physical, 
social, physiological, or cognitive metrics. 
With the reemergence of AI in healthcare 
in recent years, there has been growing 
interest to examine the role of AI within 
participatory health. The quantified-self 
movement is illustrative of the participatory 
health paradigm, where people are able to 
collect, log, and track indicators to quantify 
their health, thereby providing insight into 
their overall health status [10]. However, 
whilst arguably transformative, technolog-
ical developments in intelligent computing 
and analytical methods, namely AI, are 
providing the opportunity to go even deeper 
into understanding one’s health [11]. This 
is particularly relevant as people are able to 
collect increased types, amounts, and quality 
of data about themselves and their health. 
AI techniques and methods provide 
individuals and professionals working in the 
field of participatory health informatics with 
an opportunity to derive robust intelligence 
from online resources [12]. AI adds another 
dimension to technologies such as social 
media, and mobile devices/apps for the pur-
poses of participatory health. For example, 
through applying AI algorithmic modelling, 
multiple tasks can be performed such as: 
replicating or supplementing personalized 
medical advice from health professionals, 
diagnosing rare and complex conditions, 
informing how diseases or outbreaks develop 
and spread, predicting adverse health events, 
uncovering how people engage in certain 
health behaviors or utilize healthcare, and 
correlating experiences and outcomes from 
different treatments [13-18]. Whilst the age 
of AI offers a welcome and innovative way to 
support participatory health, the field is still 
maturing, particularly from the perspective 
of rigorous research evidence.
This paper investigates how AI impacts 
the field of participatory health and examines 
which Al applications exist for participatory 
health from both patient and clinician per-
spectives. 
2   Methodology
2.1   Search Strategy
The search strategy was developed in two 
stages. For the stage 1 search, authors pri-
marily focused on social media interventions 
within the participatory health context. This 
is because social media are one of the most 
widely used tools for individuals within the 
participatory health context. In the second 
stage of the search, the focus was related to 
other, less pervasive, participatory health 
technologies such as: mobile phones, wear-
ables, and chatbots. 
Stage 1: The PICO framework (P – Population, 
I – Intervention, C – Comparison, O – Out-
come) was followed to derive the search strat-
egy [19]. Regarding “Population”, we refered 
to various social media. “Intervention” com-
prised the multiple AI technologies and meth-
ods, and “Outcome” included the impact or 
resulting participatory health/medicine effects. 
A comparison intervention was not relevant in 
this context. Based on this topic specification, 
we created a list of relevant keywords related to 
machine learning (57 keywords), participatory 
health (12 keywords), and digital/social media 
(28 keywords). The search strategy included 
all these agreed terms. The complete literature 
search strategy is listed in the supplementay 
material (Appendix 1). The search was per-
formed on the 10th August 2018, guided by 
the recommendations of PRISMA guidelines 
[20]. The PRISMA checklist is available in 
the supplementary material (Appendix 2). 
The search covered the following databases: 
PubMed, Embase, CINAHL, PsychInfo, ACM 
Digital Library, IEEExplore, and SCOPUS. 
Stage 2: Finally, to broaden the scope and 
include future implementation of AI, we also 
included clinical trials of AI in participatory 
health. More specifically, we searched for 
relevant studies on the trial registration 
platform clinicaltrials.gov. On October 11, 
2018, we searched with the keywords “AI” 
combined with “mobile phone”, “smart-
phone”, “wearable” and the keywords 
“text-mining”, “conversational agent”, 
“chatbot”. The complete search strategy for 
clinical trials is shown in the supplementary 
material (Appendix 3).
2.2   Eligibility Criteria and Screening
We included publications published from 
2013 and onwards. These were: 1) primary 
literature or 2) reviews (scoping reviews, 
systematic reviews, or meta-analyses); 
and 3) publications that fulfilled 1) and 2). 
Publications not meeting these criteria were 
excluded. The limit of 2013 was used as 
this captures the last five years, which is the 
relevant timeframe for rapid technological 
advances like AI. Through this restriction, 
the authors wished to represent AI in its 
present state, whereas the technological 
capabilities have undergone a change in 
2013. References were imported to EndNote 
X7.8, and duplicates were removed. The first 
phase involved two independent reviewers 
(EG and OR) screening titles and abstracts 
against inclusion criteria. Full-text of articles 
meeting inclusion criteria were obtained and 
carefully examined in a second eligibility 
round. The agreed articles were included 
in this review. The search by one reviewer 
(KD) on clinicaltrials.gov identified twen-
ty-nine trials posted since January 1, 2013; 
after removing duplicates and checking for 
relevance, twelve trials were included for 
the analysis. 
2.3  Review Strategy
The resulting fulltext paper and trial infor-
mation were considered by all co-authors to 
answer the research questions:
•	 What is the current state of the art in AI 
techniques applied to data from social 
media and wearables in the context of 
participatory health?
•	 What outcomes and effects are reported 
in literature on this data using AI?
•	 Which practical implications (now and 
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future) exist from a clinical and patient 
perspective?
•	 Do clinicians feel threatened by AI? Do 
patients feel more empowered?
•	 What challenges and opportunities are 
produced by AI? What should the road-
map for future research be?
More specifically, the authors considered 
several topics in this domain and analyzed 
the retrieved literature with respect to these 
topics. These include: AI applications based 
on data from wearables and social media, and 
trials using AI in participatory health. From 
the results, we derived implications from a 
patient perspective, physician perspective, 
and from a health systems/community 
perspective. 
3   Results
The flowchart of the selection procedure is 
presented in Figure 1, while Figure 2 shows 
the trial selection procedure. It can be seen 
that we included 22 papers and 12 trials in 
the narrative synthesis. 
In this section, we first present AI appli-
cations for participatory health that were 
described in the literature. Secondly, we 
present the selected clinical trials. 
3.1   AI Applications Based on Data 
from Social Media
Of the 22 papers, 17 (77.3%) explored AI 
applications based on data from social media; 
n=13 (76.5%) were secondary analysis of data, 
and n=4 (23.5%) were literature reviews. Only 
one of the 22 papers reviewed technologies 
that involved interaction with patients or cli-
nicians and examined the capabilities of con-
versational agents for health-related purposes 
[21]. The supplementary material (Appendix 
4) provides a summary of the papers.
3.2.1   Platforms and Techniques
The most common application of AI in 
participatory health was secondary analysis 
of data, which was reported and/or reviewed 
in n=16 out of 17 papers [14, 22–35]. 
Fig. 1   Flow chart of literature selection resources from bibliographic databases.
These articles primarily reported the use 
of machine learning techniques to extract 
health-related data from electronic health 
records (EHRs) or social media. Secondary 
data analyses were conducted on general 
social networks (e.g. Facebook, Twitter, 
Instagram, Yelp, Amazon, Yahoo Q&A, 
Wikipedia, Reddit, LiveJournal), health-spe-
cific social networks (e.g. WebMD, RateMD, 
MedlinePlus, Medlinehelp.org, Breastcan-
cer.org, PatientsLikeMe, DailyStrength, 
online health forums), and EHR and clinical 
text (e.g. ShARe, i2b2, THYME).
Most literature (n=9 out of 17 studies) used 
text processing techniques, including natural 
language processing or NLP (n=4) [14, 24, 
32, 33], sentiment analysis (n=4) [14, 27, 29, 
30], and text classification (n=1) [28]. Other 
techniques included classification (3 out of 
17 studies) [22, 25, 26], clustering (3 out 
of 17) [23, 27], conversational agent (1 out 
of 17 studies) [21], deep learning (1 out of 
17 studies) [31], visualization [23, 27], and 
Latent Dirichlet Allocation [27]. 
Among the applied text processing and 
machine learning techniques, sentiment 
analysis was used to discover safety and effi-
cacy concerns in Amazon reviews for joint 
and muscle pain relief products [30]. Vocab-
ulary lists used in the analysis consisted of 
words and phrases that were more indicative 
of defective products than non-defective 
products and included non-emotive words 
that may have been missed by traditional 
sentiment analysis techniques. Another 
paper used principal components analysis 
and logistic regression to identify consumer 
health expressions (patient terminology) 
to facilitate adverse drug reactions signals 
detection among posts that do not use formal 
medical terminology [34]. A similar study 
investigated the use of applying word2vec, a 
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word embedding representation, to estimate 
the rate of adverse drug reactions to psychi-
atric drugs from social media [31]. Word 
embedding representations try to predict 
surrounding words using a central word and 
vice-versa. This technique was used to better 
find instances of adverse drug reactions in 
social media by including colloquial terms 
such as ‘can’t sleep’, in addition to medical 
terms such as ‘insomnia’. The estimates 
derived from this approach were found to 
be similar when compared with official 
rates from the SIDER database of drug side 
effects [31]. 
3.2.2   Health Conditions and AI Applications
The most common health condition exam-
ined was diabetes, which was investigated in 
n=5 papers [22-24, 26, 35]. Other conditions 
included back pain [24], hypertension [24], 
cancer (including breast cancer) [27, 28, 
35], Crohn’s disease [29], joint and muscle 
pain [29, 30], mental health [31], lung and 
respiratory disorders [32], and other chronic 
conditions [26].
Patients and consumers were the focus 
of most (n=14) papers [14, 22-32, 17, 35]. 
Consumers’ self-reported data was extracted 
from social media and included patient 
experiences at healthcare facilities [14], 
reports of adverse drug reactions of psychi-
atric medications [31], safety and efficacy 
concerns on over-the-counter medications 
[30], and perspectives on certain medications 
[21, 29]. Text-processing techniques were 
also used to detect disclosure of personal 
health status information on Twitter [25], 
identify how consumers express their health 
concerns [23, 25, 35], and extract emotional 
and informational elements in an online post 
[26]. Other applications included determin-
ing which online forum threads required 
moderator assistance [22], identifying users 
who were likely to leave an online social 
network [28], extracting terms used in a 
question posted online [27], highlighting 
contextual information that is missing from 
online questions and answers [27, 32], 
and paraphrasing technical medical terms 
for consumers [24]. Facebook data have 
revealed patients’ perspectives and opinions 
on Crohn’s disease and new treatments [29]. 
One study used conditional Latent Dirichlet 
Allocation, a weighted generative probabi-
listic model used to discover latent topics 
from a collection of documents and clusters 
of documents with similar distributions of 
medical terms, to analyze health community 
discussion threads, specifically in regards to 
physiological and psychological sentiments 
for certain conditions. Another study built 
a corpus called COPE to use social media 
to understand patient experiences at health 
care facilities in order to improve the qual-
ity of healthcare [14, 27]. This is crucial, 
as patients value doctors’ personality and 
demeanor as much as they value their med-
ical care proper [36]. 
AI has also been used to analyze patients’ 
understanding of medical conditions. One 
study used Pathfinder networks to analyze 
the differences in perception of vaccines 
between physicians and patients, shedding 
light on patients’ level of medical under-
standing and potentially helping physicians 
develop better ways of explaining medical 
issues related to vaccination [36, 37]. 
Both clinicians and consumers were the 
focus of n=3 papers [21, 33, 12]. These 
included one systematic review of conversa-
tional agents [21], and two narrative reviews 
on NLP techniques in EHR, clinical text, 
and social media [12, 33]. These reviews 
provided commentaries on the state of the 
art for their respective technology, and 
highlighted the challenges and the lack of 
rigorous studies in the field.
Lastly, AI has been used to help healthcare 
professionals in providing care to patients, 
both online and in person. One study showed 
how a low-cost text classification system 
called Linguistic Inquiry and Word Count 
(LIWC) assisted moderators in online health 
communities. The classification determined 
which posts needed moderators’ attention 
and medical expertise, and which did not. 
This provided the basis for a system that helps 
moderators prioritize a selected number of 
posts that are classified as needing medical 
Fig 2   Flow chart of trial selection from clinicaltrials.gov.
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expertise, rather than making moderators 
search through thousands of posts in the 
forum. The system also allowed moderators 
to change settings depending on how many 
posts they wanted to see [22]. A second study 
showed how AI has been used to develop a 
real-time pneumonia-screening tool to be 
used in the emergency department that pro-
vides care recommendations when pneumo-
nia is suspected from chest x-rays. Emergency 
departments that employed this tool showed 
increased adherence with recommendations 
for treatment of pneumonia [22, 33]. 
3.2.3   Summary: AI Applications in 
Participatory Health
In summary, there are several challenges 
in this line of research (e.g. working with 
unlabeled data from unstructured sources), 
with many studies that remain at the stage 
of enhancing technical performance and 
have not yet reached the maturity for user 
evaluation. Besides the review on conversa-
tional agents [21], this paper found neither 
AI applications that were designed for use 
by consumers or clinicians in participatory 
health, nor literature that elicited input from 
consumers or clinicians for such applications.
The literature to date shows that social 
media, when analyzed with AI, offers the 
opportunity to learn about patient’s expe-
riences with treatments, to study effects of 
social media interactions, and many others. 
None of the included studies reported AI 
having an effect on clinical outcomes, or 
an effect of social media on health status. 
Instead, the literature focused on:
•	 Content analysis of social media content;
•	 Term correlation and term usage analysis;
•	 Opinion or sentiment analysis with 
respect to treatments;
•	 Influence of social media interaction with 
health status.
3.2   Clinical Trials Studying AI in 
Participatory Health
In contrast to published literature aleady 
reviewed, the 12 identified clinical trials 
dealt with interventions supported by smart-
phone applications, broadly grouped in two 
categories:
•	 Capturing new kinds of data from clinical 
trials’ subjects using sensors, wearables, 
and smartphone apps; 
•	 Collecting electronic diaries and patient-re-
ported outcomes using a smartphone app.
A summary of these trials is provided in the 
supplementary material (Appendix 5). Nine 
trials tested conversational agents, either 
embodied (lifelike) or unembodied (unlife-
like); one trial assessed the efficiency of a 
smartphone application, one trial exploited a 
wearable sensor, and one study the exploita-
tion of Google glasses. Most of the trials 
randomly assigned people to interventions 
but were not blinded. The key outcomes 
were efficiency, impact, and usability of the 
systems. For example, a randomized control 
trial evaluating agent technology, i.e. com-
paring usual care versus usual care plus an 
AI agent, assessed the impact of the usage of 
the agent on the quality of life in palliative 
care [38]. Fitzpatrick et al. performed a trial 
on an automated conversational agent avail-
able as a mobile device smartphone appli-
cation that provides a cognitive behavioral 
therapy (CBT). The app allowed patients to 
immediately process and receive empathy 
for significant events and removed barriers 
traditionally limiting treatment access (cost, 
stigma, health care system navigability, and 
lack of childcare or transportation) [37]. 
Another study assessed usability, receptivity, 
and preliminary cessation when the patient 
is supported with a conversational agent for 
smoking cessation [40]. Daily adherence to 
an embodied conversational agent to use the 
mobile Kardia heart rhythm monitor has also 
been evaluated [41]. 
Two trials evaluated the smartphone 
intervention IntelliCare. It uses machine 
learning to tailor treatment for patients 
suffering from depression and anxiety. The 
system delivers patient-specific treatment 
material and motivational messaging via a 
mobile phone. The purpose of one study 
was to obtain preliminary information on the 
feasibility and effectiveness of IntelliCare 
in improving symptoms of depression and 
anxiety. The second study is a randomized 
trial with the application [42, 43]. 
An AI platform on mobile devices has 
also been used to measure and increase 
medication adherence in post stroke people 
with anticoagulation therapy. The AI appli-
cation visually identified the patient, the 
medication, and the confirmed ingestion of 
drugs [44]. Adherence was measured by pill 
counts and plasma sampling in both groups. 
Wall et al. studied the effects of an AI tool, 
running on Google Glass through an Android 
app, that performs automatic facial expres-
sion recognition and delivers social emotion 
cues to children with autism during social 
interactions. The system is designed to give 
participants non-interruptive social cues in 
real-time and to record social responses that 
can later be used to help aid behavioral ther-
apy. It studies the effects of the Autism glass 
intervention [45]. Ally, a mHealth interven-
tion to promote physical activity, is offered 
in a trial to the customers of a large Swiss 
health insurance. Interventions include the 
use of different incentive strategies, a weekly 
planning intervention and daily message 
prompts to support self-regulation [46].
In summary, registered clinical trials on 
AI in participatory health are still limited 
and are mainly evaluations of conversational 
agents interacting with patients. 
4   Discussion
AI in participatory health informatics can 
be considered as still in its infancy, as social 
media and mobile apps were a decade ago. AI 
applications within participatory health have 
been assessed in the context of a large variety 
of health conditions, health promotion activ-
ities, and healthcare settings. Furthermore, 
most evaluations have focused on refining 
AI methods and techniques, and data on the 
impact of AI on health outcomes to make 
meaningful conclusions is still awaited. To 
date the scholarship of AI in participatory 
health has been driven by researchers’ skills 
and interests, and in prevalent or challenging 
healthcare contexts, for example, the high 
prevalence of diabetes, pain, mental health 
conditions, or the demands for healthcare 
experts like neurologists, or cardiologists, 
whereby healthcare practionners with this 
expertise are geographically or numerically 
limited [47, 48]. The next immediately 
available research data, from a clinical trial 
identified in this review, will also focus on 
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health promotion or adherence to health care 
interventions and include CBT, smoking 
cessation, autism, physical activity, and med-
ication adherence [37, 40]. The very nature 
of participatory health would suggest that a 
future research agenda must be informed and 
directed by people requiring healthcare as a 
priority, but in partnership with academics 
and health care providers who understand the 
context and practicalities of providing robust 
and meaningful information and knowledge. 
4.1   Implications from the Patient 
Perspective
There is potential for AI to make significant 
improvements to the health of individuals. 
However, for the field to move forward, one 
needs to learn the lessons from the previous 
generation of technologies [21, 49, 50] to 
avoid the pitfalls in the design, evaluation, 
and implementation of patient-facing tech-
nologies. These lessons include, but are not 
limited to: mitigating high participant drop-
out, avoiding design and implementation not 
considering patients’ context or perspectives, 
and evaluating findings becoming obsolete 
by the time they are available.
Patients are often overwhelmed by what 
they need to do to manage their health. 
Many of them have busy lives and multiple 
competing priorities, and are not necessarily 
familiar with technological developments 
derived from AI. Asking patients to learn 
and adopt AI technologies to improve their 
health and wellbeing may not be something 
they wish to do, nor a priority for engage-
ment. Patients should be treated as true 
partners, with research conducted neither 
‘on’ people considered as passive subjects, 
nor on patient participants only providing 
data, but research conducted ‘with’ patients. 
Patient participants should be considered 
from initial research development to ensure 
informaticians are indeed asking the right 
questions, so that findings provide the right 
answers to improving patients’ lives [51].
Perhaps the challenge of developing 
patient-facing AI applications lies in 
human-computer interaction design, not 
the technology itself [52]. True patient ben-
efit from AI may require the design to be 
embedded deeply or even invisibly in their 
daily routine. Without getting a good under-
standing of the activities patients perform 
for their health (i.e. patient work), nor how 
their individual context, digital literacy, or 
support network affect their health and well-
being, there is a high risk that patient-facing 
technology will not be adopted, used, or 
sustained. One final challenge from this 
perspective is that of creating, or at least 
enabling and motivating behavior change 
using design and psychological mecha-
nisms, as data alone cannot be counted on to 
bring change and improve health or increase 
participation [53]. 
4.2   Implications from Physician 
Perspective
The analysis of social media data with AI 
has the potential of providing new insights 
into patient health beliefs and perspectives 
on their health, healthcare use, and efficacy 
and adverse effects of drugs and treatments. 
AI used to detect drug safety and efficacy 
concerns is attractive as doctors do not 
always elicit patient medication adherence 
and concerns about their medication [54]. 
Furthermore, concerns over side effects and 
effectiveness are among the main causes 
of non-adherence [54, 55] and they can 
be revealed by analyzing drug concerns in 
online health communities. 
Sentiment analysis applied to social 
media data can also be used to discover con-
sumers’ feedback on certain medical treat-
ments. This would be helpful to physicians 
who can gain insight into the prevalence 
of drug-related events, and how specific 
drugs work and should be repositionned. 
Additionally, consumer opinions about new 
drugs or treatments may be initially found on 
these sites. By analyzing online health social 
media data, discovery of drug-drug inter-
actions could change prescription practice, 
identify contraindications to combination 
use, or even lead to timely drug withdrawal 
from the market [56]. This research can be 
used by the healthcare and pharmaceutical 
industry to reduce risks for consumers [30, 
56]. Furthermore, it could potentially iden-
tify unexpected or infrequent drug reactions 
that would otherwise have been missed. The 
systematic mining of social media data can 
provide valuable information for physicians 
about their patients. For example, one tweet 
reads “my mom makes having cancer look 
easy”, while another reads such as “I have 
seasonal allergy”. These tweets can help 
physicians learn about their patients and 
gain insight into patients’ family medical 
history that may otherwise be missing from 
electronic medical records [25, 33]. 
Beyond this, data collected by wearables 
and through smartphone applications can 
provide insights into the health of patients. 
In particular, changes in health parameters 
become more obvious. However, what 
needs to be avoided is that physicians are 
overwhelmed with additional data to be 
assessed during patient encounters. AI can 
help in summarizing data and in discovering 
patterns in data being presented and assessed 
by physicians.
In summary, these findings show the 
promise for utilising AI at the service of 
physicians, who can use it to gain insight 
into medications and conditions. All this, 
often without the patient’s knowledge, or 
active participation.
4.3   Implications from a Health 
Systems/Community Perspective 
Information communication technology 
(ICT) has long been heralded for its potential 
to improve health systems. The power of 
larger and more readily available data sets to 
improve healthcare efficiency and effective-
ness, as well as decision-making, has long 
been debated. However, when combined with 
advances in cognitive processing and analyt-
ics, such as those afforded through AI, the 
potential for health ICT to generate health 
system level benefits increases exponentially. 
According to Accenture, growth in the AI 
health market is tipped to surpass well-over 
US$ 6 billion by 2021 [57]. 
The application of AI to participatory 
health informatics has started and focused 
on the secondary analysis of data produced 
within participatory health activity (as illus-
trated by the findings of this review with 
n=16 out of the 17 selected papers). This 
may be due in part because permissions to 
obtain access to social media and network-
ing data is easier than obtaining data from 
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custom databases related to mobile devices, 
or obtaining access to national health system 
electronic records. To date AI in participa-
tory health has focused on text-related data. 
That should not create a stereotype that 
participatory health informatics focuses on 
text data only, since there are examples that 
use EHR data. In the future it can encompass 
the use of physiological data used from wear-
able devices [58, 59] and clinical trials (as 
also identified in this review) are employing 
devices (sensors, wearables, and smartphone 
apps) to capture data. To increase knowl-
edge about impact of AI applications on 
participatory health and health outcomes, 
research frameworks and communities 
will need to work through the ethical and 
practical privacy issues of research using 
healthcare data, such as medical images 
[60], or biological data [61]. This is since 
transformative insights are most likely to 
be achieved when conventional health data 
(EHR, imaging, prescribing records) are 
combined with patient-generated data, e.g. 
both experiential reporting and physiolog-
ical data. These issues need to be urgently 
addressed by health systems, regulators, and 
society [62].
AI can also influence positive changes 
in participatory health informatics by pro-
viding insights to improve health systems 
functioning for individuals and communi-
ties. AI applications offer organizations in 
the health system insights and solutions to 
offsest rising financial pressures, increasing 
costs of healthcare, ageing populations, 
increasing incidences of complex chronic 
diseases, shortages of skilled professionals, 
and rising consumerism and digital patient 
empowerment [18, 57, 63]. If these improve 
the care experience, either directly or indi-
rectly by freeing up resources, this will have 
a positive impact on participatory health. 
Consequently, as the field matures, AI has 
the potential to assist health systems globally 
through: improved quality of healthcare, 
improved workflows, error reduction, better 
accuracy of information, enhanced safety, 
better access, greater user (patient)-centered-
ness, more personalized and preventative 
healthcare, and ultimately cost savings [18, 
57]. Furthermore, and highly relevant to the 
domain of participatory health informatics, 
is that among the top 10 application areas 
for AI proposed by Accenture, at least four 
arguably have participatory health conno-
tations, including: robotics, virtual health 
professionals/assistants, connected devices, 
and recruitment of participants into clinical 
trials [64]. Some of them have already started 
to be explored, with large areas for future 
research. 
It has been already noted that AI offers 
tremendous potential to support and prog-
ress the diagnosis of key conditions on the 
World Health Organisation’s health burden 
list [9], for example, cancer, neurological 
and cardiac conditions [11]. In these con-
ditions, the major application of AI centers 
on diagnosis and relative risk prediction. 
However, before AI can play a meaningful 
role in supporting models of participatory 
health in the community, further work and 
research is needed on its utility to support 
treatment, and emerging models of care [11, 
66]. Despite this, AI techniques are already 
being leveraged for treatment purposes, for 
example to support movement of prostheses 
in stroke and spinal cord injury [11]. 
5   Conclusions and Roadmap 
for Future Research
The authors are cognizant of the impact and 
growing interest of AI in the field of par-
ticipatory health, increased research funds 
being made available, and advances in the 
analysis, classification, and prediction of 
participatory health related data over the past 
five years. Nevertheless, many challenges 
remain to be addressed before AI is able to 
have a measurable impact on participatory 
health. More coordinated efforts between 
local, regional, and international research 
networks to develop an actionable and real-
istic research agenda for AI research in par-
ticipatory health is needed. Such a roadmap 
for research should be able to separate the 
dissonance between the hype and the reality 
of AI in participatory health informatics, 
and be actionable within the realities of the 
contemporary global healthcare context. 
There are numbers of research challenges 
as well as opportunities for AI in participa-
tory health that need to be considered. The 
introduction of AI technologies for partici-
patory health will provide health consumers 
access to a global health network including 
of healthcare services and access to other 
like-minded health consumers. Some of 
the immediate research challenges to be 
considered are where AI for participatory 
health best fits within the global healthcare 
spectrum in relation to preventive health, 
home care, primary care, secondary, and 
tertiary care. In particular, the focus should 
perhaps be put on developed nations that 
have a larger proportion of elderly indi-
viduals, versus developing countries with 
a larger proportion of young adults and 
adolescents. Also, AI-related technologies 
empower health consumers and may reduce 
health consumer reliance on medical advice 
which makes the impacts of AI on the 
patient-doctor relationship difficult to pre-
dict. Furthermore, technological advances 
in AI are increasing dramatically and eval-
uating AI impact on consumer engagement 
and general patient well-being remains to 
be investigated. An Ernst and Young 2017 
research report indicates that for participa-
tory health to become embedded within the 
healthcare system, three important elements 
must be considered: 1) capitalization on 
the advances of technology; 2) empower-
ing platforms that combine technologies, 
people, and processes; and 3) cultural shifts 
that enable the system transition towards an 
ecosystem [67]. 
Considering all these factors, there are 
a number of key and important research 
priorities that should be considered for the 
advancement of AI research in participatory 
health (Figure 3). Since healthcare ecosys-
tems are slow to change, AI technology 
will continue to advance and participatory 
health informatics will need to adapt to the 
technological advancements of AI, as more 
demands from health consumers and the 
healthcare industry place pressure on the 
overall healthcare ecosystem to use, apply, 
and accept AI technology. More work to 
understand the impact of AI on participatory 
health is needed, as explained and illustrated 
below in the suggested research priority 
areas for AI in participatory health: 
1. Evaluation - Research evaluating the 
impacts of AI on participatory health 
is needed. In particular research around 
medical errors, technology acceptance, 
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healthcare costs, quality of care, and 
impacts on decision making; 
2. Patient-Clinician Relationship - 
Research evaluating the impacts of AI on 
patient-clinician relationships is needed 
as the autonomy of physicians decreases 
due to more empowered patients, whereas 
empowerment and engagement of con-
sumers through AI technology increase; 
3. Healthcare Readiness - Healthcare 
organizations are slow to change and 
research into the readiness of healthcare 
organizations to accept AI is needed; 
4. Technology Adoption - Research to 
understand how healthcare professionals 
and consumers, of all ages, are ready to 
accept AI as a complementary or alterna-
tive type of care; 
5. Psychosocial Wellbeing - Researching 
the psychosocial impacts of participatory 
health, especially, on health consumers is 
needed as more interactions occur with an 
artificial agent vs. human interaction; 
6. Privacy and Security - Research on 
sharing health information with AI tech-
nology and the impacts on patient privacy 
and security should be addressed; 
7. Technology Advancement - As AI 
technology is advancing at a rapid pace, 
research on the types and relevance of 
AI technology for participatory health is 
required.
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